Sanofi picked up Blueprint Medicines in a deal worth up to $9.5 billion. Bristol Myers Squibb will pay $1.5 billion upfront ...

Eli Lilly also made waves locally this year for suing Houston-based Empower Pharmacy, alleging the company is selling knockoff versions of its weight-loss and diabetes medications.

Eli Lilly is evaluating a massive $5.9 billion biomanufacturing ... Meanwhile, the company is embroiled in a legal battle with Houston’s Empower Pharmacy over alleged copycat drugs, proving that ...

In response to a reporter's question, the official stated that "it would be fair to expect" that popular GLP-1 weight loss drugs, such as Eli Lilly's ... about the role of pharmacy benefit ...

So when Mounjaro’s maker, Eli Lilly, sued Empower last month for selling “knockoff” versions, the Houston pharmacy portrayed the case as “Big Pharma testing its power” against companies ...

Eli Lilly (LLY ... that one of the country's largest pharmacy benefit managers, CVS (CVS), is excluding Zepbound in favor of Wegovy on its formulary. Eli Lilly CEO David Ricks told Yahoo Finance ...

Eli Lilly (LLY) has enjoyed a successful run the ... based on the overall condition of retail pharmacy," Ricks said, referring to store closures across the country in the past few years.

Eli Lilly stock trades above all major moving averages, indicating a strongly bullish technical trend. Analysts see 3% upside, but momentum indicators suggest the rally could have more room to run.

Pharmaceutical company Eli Lilly announced promising clinical trial results this week for a daily pill to treat obesity and diabetes. Besides the good news of minimal side effects and impressive ...

In the U.S. District Court for the District of New Jersey, Eli Lilly also sued Houston-based Empower Clinic Services LLC, doing business as Empower Pharmacy, and Empower Clinic Services New Jersey ...

A Houston-based compounding pharmacy that was recently roped into Eli Lilly’s fight against ... to stop compounding tirzepatide. Lilly accused Empower of flouting that deadline in a recent ...

On April 1, Eli Lilly sued two compounding pharmacies: Strive and Empower. Strive tells NPR it ... Scott Brunner, the CEO of the Alliance for Pharmacy Compounding, an advocacy group for ...